BioPathways + Women in Bio: The Impact of COVID on Abbott’s Innovation
Date(s) - March 9, 2021
5:00 pm - 6:00 pm
BioPathways + Women in Bio:
The Impact of COVID on Abbott’s Innovation
Presenter: Andrea Wainer, Executive Vice President, Rapid and Molecular Diagnostics, Abbott.
In partnership with Women in Bio, BioPathways throughout 2021, will feature prominent female biotech founders, executives, and VCs.
Rosalind Franklin University
March 9, 2021 – 5:00 PM to 6:00 PM
For more information and to register, visit http://bit.ly/3sCYB40.